Literature DB >> 26250741

Elevated C-reactive protein and late-onset bipolar disorder in 78 809 individuals from the general population.

Marie Kim Wium-Andersen1, David Dynnes Ørsted1, Børge Grønne Nordestgaard2.   

Abstract

BACKGROUND: No prospective studies have examined the role of C-reactive protein (CRP) in late-onset bipolar disorder. AIMS: We tested the hypothesis that elevated levels of CRP are associated cross-sectionally and prospectively with late-onset bipolar disorder, and that such an association possibly is causal.
METHOD: We performed cross-sectional and prospective analyses with a median follow-up time of 5.9 years (interquartile range: 4.4-7.6) in 78 809 individuals from the general population, and used genetic variants influencing CRP levels to perform a Mendelian randomisation study.
RESULTS: Elevated levels of CRP were associated both cross-sectionally and prospectively with late-onset bipolar disorder. When CRP was on a continuous scale, a doubling in CRP yielded an observational odds ratio for late-onset bipolar disorder of 1.28 (1.08-1.52) with a corresponding causal odds ratio of 4.66 (0.89-24.3).
CONCLUSION: Elevated CRP is associated with increased risk of late-onset bipolar disorder in the general population which was supported by the genetic analysis. © The Royal College of Psychiatrists 2016.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26250741     DOI: 10.1192/bjp.bp.114.150870

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  15 in total

1.  Serum uric acid is not associated with major depressive disorder in European and South American populations: a meta-analysis and two-sample bidirectional Mendelian Randomization study.

Authors:  Zefeng Chen; Shuang Liang; Yulan Bai; Jiali Lin; Mingli Li; Zengnan Mo; Sisi Xie; ShiShan Huang; Jianxiong Long
Journal:  Eur J Clin Nutr       Date:  2022-05-25       Impact factor: 4.016

2.  Cerebrospinal Fluid Pathologies in Schizophrenia-Spectrum Disorder-A Retrospective Chart Review.

Authors:  Mattia Campana; Johanna Strauß; Susanne Münz; Tatiana Oviedo-Salcedo; Piyumi Fernando; Peter Eichhorn; Peter Falkai; Alkomiet Hasan; Elias Wagner
Journal:  Schizophr Bull       Date:  2022-01-21       Impact factor: 7.348

3.  Gender differences in longitudinal relationships between depression and anxiety symptoms and inflammation in the health and retirement study.

Authors:  Andrea N Niles; Mariya Smirnova; Joy Lin; Aoife O'Donovan
Journal:  Psychoneuroendocrinology       Date:  2018-05-28       Impact factor: 4.905

Review 4.  Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit.

Authors:  Daniel F Kripke
Journal:  F1000Res       Date:  2016-05-19

5.  Does CRP predict outcome in bipolar disorder in regular outpatient care?

Authors:  Sonya M Balukova; Bartholomeus C M Haarman; Rixt F Riemersma-van der Lek; Robert A Schoevers
Journal:  Int J Bipolar Disord       Date:  2016-07-18

6.  Serum kynurenic acid is reduced in affective psychosis.

Authors:  B E Wurfel; W C Drevets; S A Bliss; J R McMillin; H Suzuki; B N Ford; H M Morris; T K Teague; R Dantzer; J B Savitz
Journal:  Transl Psychiatry       Date:  2017-05-02       Impact factor: 6.222

Review 7.  Neuropathology of mood disorders: do we see the stigmata of inflammation?

Authors:  N Mechawar; J Savitz
Journal:  Transl Psychiatry       Date:  2016-11-08       Impact factor: 6.222

8.  Association between C-reactive protein and risk of schizophrenia: An updated meta-analysis.

Authors:  Zhichao Wang; Ping Li; Dianyuan Chi; Tong Wu; Zubing Mei; Guangcheng Cui
Journal:  Oncotarget       Date:  2017-05-18

Review 9.  Big data for bipolar disorder.

Authors:  Scott Monteith; Tasha Glenn; John Geddes; Peter C Whybrow; Michael Bauer
Journal:  Int J Bipolar Disord       Date:  2016-04-11

10.  A significant causal association between C-reactive protein levels and schizophrenia.

Authors:  Masatoshi Inoshita; Shusuke Numata; Atsushi Tajima; Makoto Kinoshita; Hidehiro Umehara; Masahito Nakataki; Masashi Ikeda; Souichiro Maruyama; Hidenaga Yamamori; Tetsufumi Kanazawa; Shinji Shimodera; Ryota Hashimoto; Issei Imoto; Hiroshi Yoneda; Nakao Iwata; Tetsuro Ohmori
Journal:  Sci Rep       Date:  2016-05-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.